Indo-U.S. Symposium

Executive Summary

FDA and the University College of Medical Sciences, University of Delhi cosponored a Feb. 18-20 conference on generic drugs, bioequivalence amd pharmacokinetics, held in New Delhi, India. The U.S. contingent included: FDAers: Marvin Seife, MD, Director Division of Generic Drugs; Shrikant Dighe, PhD, Director Division of Bioequivalence, Ramakat Mhatre, PhD, Bioequivalence Branch III Chief; Vinod Shah, PhD, Science, Management Operations and Policy Branch Chief; Walter Batts, Deputy Director of International Affairs Staff; and Dr. John Wagner, University of Michigan; Dr. James Doluisio, University of Texas; and Milton Kaplan, Parke-Davis.